| CRISPR Therapeutics AG. (2/13/24). "Press Release: European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, Casgevy (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)". Z |
2024-02-13 |
| Scinai Immunotherapeutics Ltd.. (2/13/24). "Press Release: Scinai Welcomes Liat Halpert as Head of Business Development and Sales". Jerusalem. |
2024-02-13 |
| PathAI Inc.. (2/13/24). "Press Release: PathAI Announces Exclusive Collaboration with Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics". Boston, MA. |
2024-02-13 |
| CRISPR Therapeutics AG. (2/13/24). "Press Release: CRISPR Therapeutics Announces $280 Million Registered Direct Offering". Zug & Boston, MA. |
2024-02-13 |
| Amply Discovery Ltd.. (2/12/24). "Press Release: Amply Discovery Raises £1.4m in Innovate UK Grant Funding to Tackle Complex Diseases". |
2024-02-12 |
| Repare Therapeutics Inc.. (2/12/24). "Press Release: Repare Therapeutics to Regain Global Rights to Camonsertib". Cambridge, MA & Montréal. |
2024-02-12 |
| T-Curx GmbH. (2/9/24). "Press Release: T-Curx Extends Its Management Team with Marion Jung, PhD, as Its New Chief Operating Officer". |
2024-02-09 |
| Boehringer Ingelheim. (2/8/24). "Press Release: Boehringer Ingelheim and CBmed Join Forces to Translate Novel Cancer Therapy Approaches Faster into New Medicines for Patients". Ingelheim & Graz. |
2024-02-08 |
| Vandria S.A.. (2/8/24). "Press Release: Vandria Awarded €3.8M in Prestigious Innosuisse and Eurostars Grants to Advance Innovative Drug Programs for Age-Related Diseases of the CNS and Muscle". Lausanne. |
2024-02-08 |
| BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London. |
2024-02-08 |
| Zetta Genomics Ltd.. (2/8/24). "Press Release: Zetta Genomics Expands Second Seed Funding Round with Additional £1.8 Million". |
2024-02-08 |
| FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin. |
2024-02-07 |
| VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY. |
2024-02-07 |
| MorphoSys AG. (2/5/24). "Press Release: MorphoSys Enters into Business Combination Agreement to Be Acquired by Novartis for € 2.7 Billion Equity Value. Tafasitamab Sold to Incyte". Planegg. |
2024-02-05 |
| Silence Therapeutics plc. (2/5/24). "Press Release: Silence Therapeutics Announces Oversubscribed $120 Million Private Placement". London. |
2024-02-05 |
| Theryq. (2/2/24). "Press Release: Theryq and Gustave Roussy Have Been Selected as Part of the "i-Démo" France 2030 Call for Projects". Rousset. |
2024-02-02 |
| NLC Ventures Netherlands B.V.. (2/2/24). "Press Release: NLC Health Ventures and BioScience Valuation (BSV) Announce Strategic Collaboration". Amsterdam. |
2024-02-02 |
| ITM Isotope Technologies Munich SE. (2/1/24). "Press Release: ITM Obtains Manufacturing License in the U.S.". Garching & Princeton, NJ. |
2024-02-01 |
| NeoPhore Ltd.. (2/1/24). "Press Release: NeoPhore Raises an Additional £9.6m (USD $12.2m) Series B Financing Extension to Further Progress Drug Discovery Pipeline". London. |
2024-02-01 |
| Praque.bio, z.s.. (2/1/24). "Press Release: Petra Kinzlova Became the New Director of the Prague.bio Cluster". Prague. |
2024-02-01 |
| BioNTech SE. (1/31/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305". Mainz & Shanghai. |
2024-01-31 |
| ITM Isotope Technologies Munich SE. (1/30/24). "Press Release: ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program". Garching & Vancouver, BC. |
2024-01-30 |
| Enterprise Therapeutics Ltd.. (1/30/24). "Press Release: Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing". Brighton. |
2024-01-30 |
| Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. |
2024-01-30 |
| Novonesis. (1/29/24). "Press Release: The Combination of Novozymes and Chr. Hansen Is Now Successfully Completed, Creating Novonesis – a Leading Global Biosolutions Partner". Copenhagen. |
2024-01-29 |
| Merck KGaA. (1/29/24). "Press Release: Merck Establishes First Digital Hub in Singapore". Singapore. |
2024-01-29 |
| Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna. |
2024-01-29 |
| Affluent Medical S.A.. (1/29/24). "Press Release: Affluent Medical Closes €3.5 Million Bridge via Capital Iincrease from Key Shareholders [not for US, CA, AU, or JP]". Aix-en-Provence. |
2024-01-29 |
| Formycon AG. (1/29/24). "Press Release: Gedeon Richter Becomes Strategic Investor of Formycon via Equity Investment". Munich & Budapest. |
2024-01-29 |
| Kadans Science Partner. (1/29/24). "Press Release: Kadans Becomes New Partner for Rheinland-Pfalz Location – Collaboration with Technologiezentrum Mainz". |
2024-01-29 |
| Green Elephant Biotech GmbH. (1/29/24). "Press Release (Blog Post): Product Launch. Green Elephant Biotech Launches the World's First Plant-based 96-well Plate". |
2024-01-29 |
| SGS S.A.. (1/26/24). "Press Release: SGS 2023 Full Year Results and Strategic Update". |
2024-01-26 |
| SGS S.A.. (1/26/24). "Press Release: Géraldine Picaud to Succeed Frankie Ng as Chief Executive Officer". |
2024-01-26 |
| Repare Therapeutics Inc.. (1/25/24). "Press Release: Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment". Cambridge, MA & Montréal. |
2024-01-25 |
| Bruker Corporation. (1/25/24). "Press Release: Bruker Announces Agreement to Acquire Chemspeed". Basel. |
2024-01-25 |
| InflaRx N.V.. (1/25/24). "Press Release: InflaRx Announces Initiation of Its Commitment Program for GOHIBIC (vilobelimab) to Help Broaden Access for Eligible Patients". Ann Arbor, MI. |
2024-01-25 |
| IMU Biosciences (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. |
2024-01-24 |
| BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. |
2024-01-24 |
| BioLizard N.V.. (1/23/24). "Press Release: BioLizard Opens Office in Switzerland – AI-powered Digital Transformation of Life Sciences at Biopôle in Lausanne". Lausanne & Ghent. |
2024-01-23 |
| Bruker Corporation. (1/23/24). "Press Release: Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts". Zürich & Newton, MA. |
2024-01-23 |
| Hephaistos-Pharma SAS. (1/23/24). "Press Release: Hephaistos-Pharma Secures a €2 Million Seed Round with Xista Science Ventures, Foundation Fournier-Majoie and Noshaq". Orsay. |
2024-01-23 |
| BioNTech SE. (1/22/24). "Press Release: BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer". Mainz & Shanghai. |
2024-01-22 |
| CureVac N.V.. (1/17/24). "Press Release: CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock". Tübingen & Boston, MA. |
2024-01-17 |
| ITM Isotope Technologies Munich SE. (1/16/24). "Press Release: ITM Appoints Dr. Mark Harfensteller as Member of Its Executive Board". Garching. |
2024-01-16 |
| Stalicla S.A.. (1/16/24). "Press Release: Stalicla Secures $17.4 Million in Series B Financing to Propel Precision Neuro Advancements". Geneva. |
2024-01-16 |
| Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich. |
2024-01-16 |
| BIO Deutschland e. V.. (1/11/24). "Press Release: Biotech Industry. Financing Remains Stable – Turnaround on the Horizon". Berlin. |
2024-01-11 |
| WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai. |
2024-01-11 |
| Roche Deutschland Holding GmbH. (1/10/24). "Press Release: Prof. Hagen Pfundner wird zum 1. Mai 2024 Vorsitzender der Roche Deutschland Holding GmbH". |
2024-01-10 |
| Catalym GmbH. (1/9/24). "Press Release: Catalym Appoints Drug Development Leader Roy Baynes to its Board of Directors and Strengthens Scientific Advisory Board with Three Accomplished Lung and Bladder Cancer Specialists". Mainz. |
2024-01-09 |
| BioNTech SE. (1/9/24). "Press Release: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference". Mainz. |
2024-01-09 |
| Calypso Biotech B.V.. (1/8/24). "Press Release: Calypso Enters into Agreement to Be Acquired by Novartis". Amsterdam. |
2024-01-08 |
| CellPhenomics GmbH. (1/8/24). "Press Release: CellPhenomics and Charles River Announce Agreement, Expanding 3D in vitro Services for Cancer Therapy Drug Screening". Berlin & Wilmington, MA. |
2024-01-08 |
| Eckert & Ziegler AG. (1/8/24). "Press Release: Eckert & Ziegler and ArtBio Announce Manufacturing and Supply Partnership for Lead-212 Conjugates". Berlin & Cambridge, MA. |
2024-01-08 |
| Aion Labs. (1/8/24). "Press Release: Aion Labs Welcomes Amiti as Strategic Partner to Accelerate Israel's Position as a Leading Hub for Transformative AI-Powered Drug Discovery Innovation". Rehovot. |
2024-01-08 |
| Shanghai Argo Biopharmaceutical Co., Ltd.. (1/7/24). "Press Release: Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis". Shanghai. |
2024-01-07 |
| Vico Therapeutics B.V.. (1/5/24). "Press Release: Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline". Leiden. |
2024-01-05 |
| GlycoEra AG. (1/5/24). "Press Release: GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer". Newton, MA & Wädenswil. |
2024-01-05 |
| CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA. |
2024-01-05 |
| SanReno Therapeutics. (1/5/24). "Press Release: SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease". Shanghai. |
2024-01-05 |
| Immunic, Inc.. (1/5/24). "Press Release: Immunic, Inc. Announces Private Placement of up to $240 Million". New York, NY. |
2024-01-05 |
| Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo. |
2024-01-04 |
| Resalis Therapeutics S.r.l.. (1/4/24). "Press Release: Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity". Torino. |
2024-01-04 |
| Boehringer Ingelheim. (1/4/24). "Press Release: Boehringer Ingelheim and 3T Biosciences Enter into a Second Partnership to Develop Next-generation Cancer Immunotherapies". Oxford. |
2024-01-04 |
| Enara Bio Ltd.. (1/4/24). "Press Release: Boehringer Ingelheim Licenses Multiple Dark Antigens from Enara Bio to Develop Off-the-Shelf Immunotherapies for Non-small Cell Lung Cancer (NSCLC)". Oxford. |
2024-01-04 |
| Evotec SE. (1/4/24). "Press Release: Evotec and Owkin Enter an A.I.-powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I". Hamburg & Paris. |
2024-01-04 |
| Full-Life Technologies. (1/4/24). "Press Release: Global Radiotherapeutics Company Full-Life Technologies Announces USD $47.3 Million Series B Financing, Prosperity7 Ventures Jointly Leads the Round". Shanghai, Gembloux & Heidelberg. |
2024-01-04 |
| ITM Isotope Technologies Munich SE. (1/4/24). "Press Release: ITM Announces Operational Readiness for NOVA Facility, the World’s Largest Lutetium-177 Production Site". Garching. |
2024-01-04 |
| Human Immunology Biosciences, Inc. (HI-Bio). (1/4/24). "Press Release: HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases". South San Francisco, CA. |
2024-01-04 |
| Moma Therapeutics, Inc.. (1/4/24). "Press Release: Moma Therapeutics Announces Five-Year Discovery Collaboration with Roche Focused on Critical Cancer Dependencies". Cambridge, MA. |
2024-01-04 |
| Bruker Corporation. (1/3/24). "Press Release: Bruker Acquires Electron Microscopy Company Nion". Billerica, MA. |
2024-01-03 |
| Evotec SE. (1/3/24). "Press Release: Evotec Announces CEO Transition. Dr. Werner Lanthaler to Step Down as CEO". Hamburg. |
2024-01-03 |
| Boehringer Ingelheim. (1/3/24). "Press Release: Boehringer Ingelheim Partners with Ribo to Develop New Treatments for People with Liver Diseases". Ingelheim, Mölndal & Kunshan. |
2024-01-03 |
| CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA. |
2024-01-03 |
| Qiagen N.V.. (1/3/24). "Press Release: Qiagen Expands Business in Middle East with New Regional Headquarters and Major Projects". Venlo, Muscat & Ryadh. |
2024-01-03 |
| Remix Therapeutics, Inc.. (1/3/24). "Press Release: Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing". Watertown, MA. |
2024-01-03 |
| Affimed N.V.. (1/3/24). "Press Release: Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck". Mannheim. |
2024-01-03 |
| MediLink Therapeutics (Suzhou) Co., Ltd.. (1/2/24). "Press Release: MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to Develop Next-generation Antibody Drug Conjugate in Oncology". Suzhou. |
2024-01-02 |
| Roche. (12/29/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire LumiraDx's Point of Care Technology Combining Multiple Diagnostic Modalities on a Single Platform". Basel. |
2023-12-29 |
| Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/27/23). "Press Release: New Agent Regulates Serotonin Production". Berlin. |
2023-12-27 |
| PAI Partners SAS. (12/27/23). "Press Release: PAI Partners Enters into Agreement for the Sale of ELITech Group to Bruker Corporation". |
2023-12-27 |
| Eli Lilly and Company. (12/27/23). "Press Release: Lilly Completes Acquisition of Point Biopharma". Indianapolis, IN. |
2023-12-27 |
| Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners]
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest eve |
2023-12-26 |
| Paion AG. (12/22/23). "Press Release: Sale of the Business Operations". Aachen. |
2023-12-22 |
| UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". |
2023-12-21 |
| Hookipa Pharma Inc.. (12/21/23). "Press Release: Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences". New York, NY & Vienna. |
2023-12-21 |
| ITM Isotope Technologies Munich SE. (12/21/23). "Press Release: ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Garching. |
2023-12-21 |
| Agilent Technologies Inc.. (12/20/23). "Press Release: Agilent Makes Strategic Updates to Organizational Structure". Santa Clara, CA. |
2023-12-20 |
| Simris Group AB. (12/20/23). "Press Release: Simris Biologics Signs Material Transfer Agreement with Pre-clinical Biotech Company to Develop Linker-Payloads". |
2023-12-20 |
| CureVac N.V.. (12/19/23). "Press Release: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE". Tübingen. |
2023-12-19 |
| LimmaTech Biologics AG. (12/19/23). "Press Release: LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc’s Innovative Vaccine Candidate Against Staphylococcus aureus". Schlieren & Rockville, MD. |
2023-12-19 |
| Miltenyi Biotec B.V. & Co. KG. (12/18/23). "Press Release: Miltenyi Biotec and Replay’s Oncology-focused Product Company Syena Enter into Exclusive Licensing and GMP Manufacturing Agreement for PRAME TCR-NK Cell Therapy Based on CliniMACS Prodigy". Bergi |
2023-12-18 |
| SGS S.A.. (12/18/23). "Press Release: SGS Signs Agreement to Divest Crop Science Operations to Eurofins Scientific [ Ad hoc announcement pursuant to Art. 53 LR ]
". |
2023-12-18 |
| BioNTech SE. (12/18/23). "Press Release: BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda". Kigali. |
2023-12-18 |
| HealthTech For Care. (12/18/23). "Press Release: HealthTech For Care Makes Governance Changes, Appointing Pierre Courteille as Chairman and Sophie Villedieu as Managing Director". Paris. |
2023-12-18 |
| AC Immune S.A.. (12/15/23). "Press Release: AC Immune Announces Pricing of Underwritten Offering of Common Shares". Lausanne. |
2023-12-15 |
| AC Immune S.A.. (12/15/23). "Press Release: AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO". Lausanne. |
2023-12-15 |
| EMBL. (12/14/23). "Press Release: Using Artificial Intelligence to Discover Therapeutic Antibodies". |
2023-12-14 |
| Life Science Nord Management GmbH. (12/14/23). "Press Release: Dr. Jürgen Walkenhorst Is Leaving Life Science Nord". |
2023-12-14 |
| MorphoSys AG. (12/14/23). "Press Release: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million [Not for US, AU, ZA, JP, et al.]". Planegg. |
2023-12-14 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 6 7 8 ... 40 41 42 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
